T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Brain : a journal of neurology

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/brain/awy069PMID 29659729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recognition of viral and self‐antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses

  2017cited by this paper
• Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal

  2017influential reference
• T cell responses in the central nervous system

  2017cited by this paper
• Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients

  2017cited by this paper
• Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients

  2017cited by this paper
• Increased expression of Tbet in CD4+ T cells from clinically isolated syndrome patients at high risk of conversion to clinically definite MS

  2016cited by this paper
• Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins

  2016cited by this paper
• Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression

  2016cited by this paper
• Distinct T cell signatures define subsets of patients with multiple sclerosis

  2016cited by this paper
• Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration

  2016cited by this paper
• Multiple sclerosis—a quiet revolution

  2015cited by this paper
• Gatekeeper role of brain antigen‐presenting CD11c+ cells in neuroinflammation

  2015cited by this paper
• Immunopathology of multiple sclerosis

  2015cited by this paper
• Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation

  2015cited by this paper
• The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis.

  2015cited by this paper
• Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis

  2015influential reference
• GM‐CSF promotes migration of human monocytes across the blood brain barrier

  2015cited by this paper
• First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks

  2014cited by this paper
• Regulatory T cells in autoimmune neuroinflammation

  2014cited by this paper
• Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis

  2014cited by this paper
• Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids

  2014cited by this paper
• Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells

  2014cited by this paper
• VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells

  2014influential reference
• Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

  2014cited by this paper
• [Immunopathology of multiple sclerosis].

  2014cited by this paper
• IL-1β Promotes the Differentiation of Polyfunctional Human CCR6+CXCR3+ Th1/17 Cells That Are Specific for Pathogenic and Commensal Microbes

  2014cited by this paper
• IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells

  2014influential reference
• Main features of human T helper 17 cells

  2013cited by this paper
• IFN-γ-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair.

  2013cited by this paper
• The CD226/CD155 Interaction Regulates the Proinflammatory (Th1/Th17)/Anti-Inflammatory (Th2) Balance in Humans

  2013cited by this paper
• Capture, crawl, cross: the T cell code to breach the blood-brain barriers.

  2012cited by this paper
• Clinically isolated syndromes.

  2012cited by this paper
• Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML

  2012cited by this paper
• Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.

  2012influential reference
• Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system.

  2012cited by this paper
• RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation

  2011cited by this paper
• How do immune cells overcome the blood–brain barrier in multiple sclerosis?

  2011cited by this paper
• Immune reconstitution inflammatory syndrome in natalizumab-associated PML

  2011cited by this paper
• The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF

  2011cited by this paper
• Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

  2011cited by this paper
• Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE

  2011cited by this paper
• Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis

  2010cited by this paper
• Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells

  2009cited by this paper
• Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis.

  2009influential reference
• Preferential recruitment of interferon‐γ–expressing TH17 cells in multiple sclerosis

  2009influential reference
• β1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity

  2009cited by this paper
• C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE

  2009influential reference
• IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice.

  2008cited by this paper
• Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event

  2008cited by this paper
• Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells

  2008cited by this paper
• GM-CSF Production by Autoreactive T Cells Is Required for the Activation of Microglial Cells and the Onset of Experimental Autoimmune Encephalomyelitis1

  2007cited by this paper
• Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

  2007cited by this paper
• Clinically isolated syndromes

  2007cited by this paper
• Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells

  2007cited by this paper
• Immune surveillance in multiple sclerosis patients treated with natalizumab

  2006cited by this paper
• A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

  2006cited by this paper
• Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line

  2005cited by this paper
• Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis

  2002cited by this paper
• Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis

  2001cited by this paper
• Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

  1993cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

  1965cited by this paper

• B-cell abundance in perivascular cuffs associates with local lesion activity in multiple sclerosis.

  2026cites this paper
• Resident T cells in the healthy and multiple sclerosis brain.

  2026cites this paper
• Dynamics and Impact of Repopulating Microglia Following Oligodendroglial Damage

  2026cites this paper
• Reconstitution of CXCR3 + CCR6 + Th17.1‐Like T Cells in Response to Ofatumumab Therapy in Patients With Multiple Sclerosis

  2025influential citation
• Chemokines as therapeutic targets for multiple sclerosis: a spatial and chronological perspective

  2025cites this paper
• Immunopathology of optic neuritis and cerebrospinal fluid biomarkers for acute attack and relapse prediction

  2025influential citation
• Traditional medicine meets modern science: Halofuginone’s role in combating autoimmune diseases

  2025cites this paper
• Immunological microenvironment and targeted therapeutics in multiple sclerosis: new insights in crosstalk between immune niches and CNS

  2025cites this paper
• The Quinazoline Derivative, QNZ, Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells

  2025cites this paper
• Neuroinflammation: An Oligodendrocentric View

  2025cites this paper
• Pro‐Inflammatory c‐Met+ CD4 T Cells in Multiple Sclerosis

  2025cites this paper
• K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity

  2025cites this paper
• Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins

  2025cites this paper
• Regulatory T cell plasticity and immune deviation toward autoinflammation in HTLV-1-associated diseases: insights and implications

  2025cites this paper
• Exploring the Link Between Allergies and Neurological Diseases: Unveiling the Hidden Connections

  2025cites this paper
• Acquisition of residency programs by T cells entering the human brain.

  2025cites this paper
• Mouse Model of Sutured Endothelial Keratoplasty Technique

  2025cites this paper
• Multiple sclerosis-like manifestations in systemic autoimmune and inflammatory disorders: an update

  2025cites this paper
• Multimodal relationships and multifactorial associations between oral microecological and neurodegenerative diseases.

  2025cites this paper
• A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populations

  2025cites this paper
• Changes in T lymphocyte subsets in patients with acute neuromyelitis optica spectrum disorder

  2025cites this paper
• Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis

  2025cites this paper
• STAT3 S727 phosphorylation drives pathogenic Th17 differentiation and neuroinflammation in autoimmune disease

  2025cites this paper
• Migration arrest and transendothelial trafficking of human pathogenic-like Th17 cells are mediated by differentially positioned chemokines

  2025cites this paper
• Machine Learning Algorithms Introduce Evoked Potentials As Alternative Biomarkers for the Expanded Disability Status Scale Prognosis of Multiple Sclerosis Patients

  2025cites this paper
• Mechanisms of Glucocorticoid Resistance in Nonclassical T Helper Populations Th17.1/Ex-Th17

  2025influential citation
• The immunological paradox of CD4⁺ T cells in traumatic brain injury (Review Article).

  2025cites this paper
• Augmenting antitumor efficacy of Th17-derived Th1 cells through IFN-γ-induced type I interferon response network via IRF7

  2024cites this paper
• Chemokines in neurodegenerative diseases

  2024cites this paper
• Choroid plexus volume as a marker of retinal atrophy in relapsing remitting multiple sclerosis.

  2024cites this paper
• Ocrelizumab associates with reduced cerebrospinal fluid B and CD20dim CD4+ T cells in primary progressive multiple sclerosis

  2024cites this paper
• Novel insights into the ROCK-JAK-STAT signaling pathway in upper respiratory tract infections and neurodegenerative diseases

  2024cites this paper
• Targeting cytokine networks in neuroinflammatory diseases

  2024cites this paper
• Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies

  2024cites this paper
• Sportizumab - Multimodal progressive exercise over 10 weeks decreases Th17 frequency and CD49d expression on CD8+ T cells in relapsing-remitting multiple sclerosis: A randomized controlled trial.

  2024cites this paper
• Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS.

  2024cites this paper
• Sequential administration of paricalcitol followed by IL-17 blockade for progressive refractory IgA nephropathy patients

  2024cites this paper
• Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis

  2024cites this paper
• Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis

  2024cites this paper
• CXCR3-Expressing T Cells in Infections and Autoimmunity.

  2024cites this paper
• Role of autoreactive Tc17 cells in the pathogenesis of experimental autoimmune encephalomyelitis

  2024cites this paper
• Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis

  2024cites this paper
• Neutrophil/lymphocyte and monocyte/lymphocyte indexes as potential predictors of relapse at 1 year after diagnosis of pediatric multiple sclerosis: a single-center, exploratory and proof-of-concept study

  2024cites this paper
• Re-establishing immune tolerance in multiple sclerosis: focusing on novel mechanisms of mesenchymal stem cell regulation of Th17/Treg balance

  2024cites this paper
• Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case-control study

  2024cites this paper
• Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?

  2024cites this paper
• Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine

  2024cites this paper
• Modification of T- and B-cell-associated immuno-pathologic mechanisms in multiple sclerosis by disease modifying therapies: Achievements and opportunities.

  2024cites this paper
• Differential Runx3, Eomes, and T‐bet expression subdivides MS‐associated CD4+ T cells with brain‐homing capacity

  2023influential citation
• Th17 Cells, Glucocorticoid Resistance, and Depression

  2023cites this paper
• The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatment.

  2023cites this paper
• Cerebral microvascular endothelial cell-derived extracellular vesicles regulate blood − brain barrier function

  2023cites this paper
• The Effect of PEGylated Graphene Oxide Nanoparticles on the Th17-Polarization of Activated T Helpers

  2023cites this paper
• Comparing HD knockin pigs and mice reveals the pathological role of IL-17.

  2023cites this paper
• Research Progress on Th17.1 Cells and Pathogenesis of Systemic Lupus Erythematosus

  2023cites this paper
• Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance

  2023cites this paper
• Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis

  2023cites this paper
• MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.

  2023cites this paper
• Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients.

  2023cites this paper
• Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice.

  2023cites this paper
• Multiple Sclerosis and Sodium Toxicity: Controversy and Future Directions for Low-Salt Interventions

  2023cites this paper
• Matrine Mediated Immune Protection in MS by Regulating Gut Microbiota and Production of SCFAs

  2023cites this paper
• A2AR antagonist treatment for multiple sclerosis: Current progress and future prospects.

  2023cites this paper
• Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control

  2023influential citation
• Pathogenic Th17 cells in autoimmunity with regard to rheumatoid arthritis.

  2023cites this paper
• Cytokine Gene Polymorphisms in Patients with Chronic Inflammatory Demyelinating Polyneuropathy

  2023cites this paper
• Cladribine Effects on T and B Cells and T Cell Reactivity in Multiple Sclerosis

  2023cites this paper
• High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro

  2023cites this paper
• Unraveling the Immunopathogenesis of Multiple Sclerosis: The Dynamic Dance of Plasmablasts and Pathogenic T Cells

  2023cites this paper
• Rituximab induces a transient fluctuation of peripheral and follicular helper T cells in neuromyelitis optica spectrum disorder.

  2023cites this paper
• Th17/IL-17 Axis in HTLV-1-Associated Myelopathy Tropical Spastic Paraparesis and Multiple Sclerosis: Novel Insights into the Immunity During HAMTSP

  2023cites this paper
• Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic

  2023cites this paper
• Zinc finger protein 189 promotes the differentiation of lamina propria T helper 17.1 cells in dextran sulfate sodium-induced colitis

  2023cites this paper
• S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells.

  2023cites this paper
• Effects of glycodelin on CCR6+ cell subpopulations of Th17-polarized helper T cells

  2023cites this paper
• Oral Cladribine Impairs Intermediate, but Not Conventional, Monocyte Transmigration in Multiple Sclerosis Patients across a Model Blood-Brain Barrier

  2023cites this paper
• Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment

  2023cites this paper
• Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis

  2023cites this paper
• Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers

  2022cites this paper
• Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound

  2022cites this paper
• Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma

  2022cites this paper
• Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis

  2022cites this paper
• Dynamics of T cell repertoire renewal following autologous hematopoietic stem cell transplantation in multiple sclerosis

  2022cites this paper
• A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis

  2022cites this paper
• Therapeutic Effect of Rapamycin-Loaded Small Extracellular Vesicles Derived from Mesenchymal Stem Cells on Experimental Autoimmune Uveitis

  2022cites this paper
• Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities

  2022cites this paper
• Correlation between the Neutrophil-to-Lymphocyte Ratio and Multiple Sclerosis: Recent Understanding and Potential Application Perspectives

  2022cites this paper
• Osteopontin associates with brain TRM-cell transcriptome and compartmentalization in donors with and without multiple sclerosis

  2022cites this paper
• Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis.

  2022cites this paper
• Alterations of subset and cytokine profile of peripheral T helper cells in PBMCs from Multiple Sclerosis patients or from individuals with MS risk SNPs near genes CYP27B1 and CYP24A1.

  2022cites this paper
• The Airway Microbiome-IL-17 Axis: a Critical Regulator of Chronic Inflammatory Disease

  2022cites this paper
• Chemokine-Driven Migration of Pro-Inflammatory CD4+ T Cells in CNS Autoimmune Disease

  2022cites this paper
• Astrocytes and Inflammatory T Helper Cells: A Dangerous Liaison in Multiple Sclerosis

  2022cites this paper
• Neuroinflammation: Extinguishing a blaze of T cells

  2022cites this paper
• Elevated proportion of TLR2- and TLR4-expressing Th17-like cells and activated memory B cells was associated with clinical activity of cerebral cavernous malformations

  2022cites this paper
• Brain Antigens Stimulate Proliferation of T Lymphocytes With a Pathogenic Phenotype in Multiple Sclerosis Patients

  2022cites this paper
• T-cell surveillance of the human brain in health and multiple sclerosis

  2022cites this paper
• Multiple sclerosis: Immunopathological heterogeneity and its implications

  2022cites this paper
• A sharp decrease of Th17, CXCR3+-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis

  2022cites this paper
• Characterizing memory T helper cells in patients with psoriasis, subclinical, or early psoriatic arthritis using a machine learning algorithm

  2022cites this paper